| 1 |
Fan E, Brodie D, Slutsky AS. Acute respiratory distress syndrome: advances in diagnosis and treatment[J]. JAMA, 2018, 319(7): 698-710.
|
| 2 |
罗 婷，张 实. 5种生物标志物对ARDS预后的预测分析[J/CD]. 中华肺部疾病杂志(电子版), 2023, 16(4): 471-475.
|
| 3 |
Gattinoni L, Busana M, Giosa L, et al. Prone positioning in acute respiratory distress syndrom[J]. Semin Respir Crit Care Med, 2019, 40(1): 94-100.
|
| 4 |
Huang X, Zhang X, Zhao DX, et al. Endothelial hypoxia-inducible factor-1α is required for vascular repair and resolution of inflammatory lung injury through forkhead box protein m1[J]. Am J Pathol, 2019, 189(8): 1664-1679.
|
| 5 |
Shibaki R, Murakami S, Shinno Y, et al. Predictive value of serum VEGF levels for elderly patients or for patients with poor performance status receiving anti-PD-1 antibody therapy for advanced non-small-cell lung cancer[J]. Cancer Immunol Immunother, 2020, 69(7): 1229-1236.
|
| 6 |
Melincovici CS, Boşca AB, Şuşman S, et al. Vascular endothelial growth factor (VEGF) -key factor in normal and pathological angiogenesis[J]. Rom J Morphol Embryol, 2018, 59(2): 455-467.
|
| 7 |
ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the Berlin Definition[J]. JAMA, 2012, 307(23): 2526-2533.
|
| 8 |
刘大伟. 实用重症医学诊疗[M]. 天津：天津科学技术出版社，2014: 106-112.
|
| 9 |
Gilani MT, Razavi M, Azad AM. A comparison of simplified acute physiology score Ⅱ，acute physiology and chronic health evaluation Ⅱ and acute physiology and chronic health evaluation Ⅲ scoring system in predicting mortality and length of stay at surgical intensive care unit[J]. Niger Med J, 2014, 55(2): 144-147.
|
| 10 |
Wang H, Ye L, Yu L, et al. Performance of sequential organ failure assessment, logistic organ dysfunction and multiple organ dysfunction score in severe sepsis within Chinese Iintensive Care Units[J]. Anaesth Intensive Care, 2011, 39(1): 55-60.
|
| 11 |
李 虹，李一丹，朱维维，等. 高频胸膜肺超声对呼吸困难患者肺部疾病的诊断价值：与CT对照研究[J]. 中华超声影像学杂志，2016, 25(4): 305-308.
|
| 12 |
Huppert LA, Matthay MA, Ware LB. Pathogenesis of acute respiratory distress syndrome[J]. Semin Respir Crit Care Med, 2019, 40(1): 31-39.
|
| 13 |
韩 虎，袁 军，李建国. 血管外肺水指数结合血乳酸清除率、APACHEⅡ评分对ARDS患者近期预后不良的预测价值[J]. 重庆医学，2023, 52(3): 321-325，332.
|
| 14 |
许瑞涛，李双凤，黄淑雅，等. 乳酸清除率联合多配体聚糖-1对脓毒性休克并急性呼吸窘迫综合征预后的预测价值[J]. 中华急诊医学杂志，2023, 32(5): 660-666.
|
| 15 |
李乐辉，罗凌青，饶 平，等. 急性呼吸窘迫综合征患者血清可溶性CD14、LBP水平与预后的关系研究[J]. 临床肺科杂志，2019, 24(6): 1030-1033.
|
| 16 |
吴爱萍，王金柱，韩 芳，等. 基于柏林标准诊断的急性呼吸窘迫综合征患者预后影响因素研究[J]. 中国全科医学，2019, 22(18): 2176-2181.
|
| 17 |
Munshi L, Walkey A, Goligher E, et al. Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis[J]. Lancet Respir Med, 2019, 7(2): 163-172.
|
| 18 |
Serebrovska ZO, Chong EY, Serebrovska TV, et al. Hypoxia, HIF-1α，and COVID-19: from pathogenic factors to potential therapeutic targets[J]. Acta Pharmacol Sin, 2020, 41(12): 1539-1546.
|
| 19 |
徐 峰，扆 鹏，高海晋，等. 乌司他丁联合短程小剂量甲泼尼龙对脓毒症合并ARDS患者临床结局及炎症因子水平的影响[J]. 中华生物医学工程杂志，2022, 28(2): 189-193.
|
| 20 |
韩春艳，赵君焱. 血清HIF-1α，VEGF, Flt-1检测在急性呼吸窘迫综合征患者中的临床意义及预后评估价值[J]. 中国急救复苏与灾害医学杂志，2022, 17(10): 1331-1335.
|
| 21 |
贾仲瑞，李艳秋，陈广生，等. 血清HIF-1α、VEGF水平与急性呼吸窘迫综合征临床预后的关系[J]. 热带医学杂志，2019, 19(7): 886-889，902.
|
| 22 |
Zhou S, Yin DP, Wang Y, et al. Dynamic changes in growth factor levels over a 7-day period predict the functional outcomes of traumatic brain injury[J]. Neural Regen Res, 2018, 13(12): 2134-2140.
|
| 23 |
林红卫，李王平，金发光. PM2.5激活HIF-1α-NF-κB/VEGF通路对肺损伤的影响[J/CD]. 中华肺部疾病杂志(电子版), 2022, 15(3): 316-322.
|
| 24 |
谢克难，樊志伟，刘 磊. VEGF对闭合性胸外伤合并ARDS发生和病情预测中的临床价值[J]. 中国实验诊断学，2019, 23(6): 944-947.
|
| 25 |
樊志伟，随 涛，谢克难，等. 血府逐瘀汤经直肠滴注对胸外伤并发ARDS患者血清VEGF、炎症因子水平的影响及临床疗效研究[J]. 四川中医，2020, 38(12): 183-186.
|
| 26 |
陈 城，崔 静，纪小奇，等. 维生素C联合乌司他丁对脓毒症伴ARDS患者血管内皮功能的保护作用研究[J]. 临床和实验医学杂志，2023, 22(6): 579-583.
|
| 27 |
刘 洁，张建刚，马登飞. 电针对脑梗死患者血清VEGF/Flt-1、BDNF表达以及临床效果的影响[J]. 中华中医药学刊，2023, 41(3): 231-234.
|
| 28 |
崔 刚，软 洋，金星林. Ki-67、VEGF、Flt-1在肝细胞癌中的表达及意义[J]. 中国现代医学杂志，2013, 23(3): 27-31.
|
| 29 |
Hao D, Li Y, Zhao G, et al. Soluble fms-like tyrosine kinase-1-enriched exosomes suppress the growth of small cell lung cancer by inhibiting endothelial cell migration[J]. Thorac Cancer, 2019, 10(10): 1962-1972.
|
| 30 |
Dupont V, Kanagaratnam L, Goury A, et al. Excess soluble fms-like tyrosine kinase 1 correlates with endothelial dysfunction and organ failure in critically ill COVID-19 patients[J]. Clin Infect Dis, 2020, 18(6): 172-179.
|